Brief: TCR² Therapeutics Says Public Offering Of 8 Mln Common Shares Priced At $15.50/SHR
29/07/2020 02:27
July 28 (Reuters) - TCR2 Therapeutics Inc TCRR.O :
* TCR² THERAPEUTICS ANNOUNCES PRICING OF PUBLIC OFFERING OF
COMMON
STOCK
* SAYS PUBLIC OFFERING OF 8.00 MILLION COMMON SHARES PRICED
AT
$15.50PER SHARE
Source text for Eikon: ID:nGNX5vRpTs
Further company coverage: TCRR.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on TCR2 Therapeutics
See all newsBrief: TCR2 Therapeutics Entered Into An Assignment Of Lease Agreement With Astrazeneca
TCR2 Therapeutics falls on bigger-than-expected Q1 loss
Brief: Tcr² Therapeutics Reports Q1 2023 Financial Results And Provides Corporate Update
TCR2 Therapeutics Inc reports results for the quarter ended in March - Earnings Summary
TCR2 Therapeutics Inc expected to post a loss of 68 cents a share - Earnings Preview